Ado-trastuzumab emtansine and SymlinPen 60

• Generic Name: ado-trastuzumab emtansine
• Dosage Forms: n.a.
• Other Brand Names: Kadcyla

Ado-trastuzumab emtansine is used to treat a HER2-positive breast cancer. ado-trastuzumab emtansine is used both for early breast cancer and for breast cancer that has spread to other parts of the body (metastatic).

Ado-trastuzumab emtansine is usually given after other treatments have failed.

Kadcyla (ado-trastuzumab) should not be used in place of Herceptin (trastuzumab).

Ado-trastuzumab emtansine may also be used for purposes not listed in this medication guide.

• Generic Name: pramlintide
• Dosage Forms: n.a.
• Other Brand Names: SymlinPen 120, SymlinPen 60, Symlin

SymlinPen 60 is a man-made form of a hormone that occurs naturally in the body. This medicine lowers blood sugar in three ways. It slows the rate that food moves from your stomach to your intestines, which keeps your blood sugar from rising too fast. This medicine also lowers the amount of glucose (sugar) your liver produces. Lastly, this medicine triggers the feeling of fullness after meals to help control your appetite and decrease how much food you eat.

SymlinPen 60 is used together with insulin to treat type 1 or type 2 diabetes. This medicine is usually given after other diabetes medicines have been tried without success.

SymlinPen 60 may also be used for purposes not listed in this medication guide.